Skip to main content
EuBiologics Co., Ltd. logo

EuBiologics Co., Ltd. — Investor Relations & Filings

Ticker · 206650 ISIN · KR7206650004 KO Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2021-06-14 Major Shareholding Noti…
Country KR South Korea
Listing KO 206650

About EuBiologics Co., Ltd.

http://eubiologics.com/eng/

EuBiologics Co., Ltd. is a biopharmaceutical company focused on improving global public health through the development and supply of safe and effective vaccines. The company specializes in preventative vaccines against global pandemics and emerging infectious diseases, with a key product being its oral cholera vaccine. In addition to its vaccine pipeline, EuBiologics provides Contract Research and Manufacturing Organization (CRMO) services. These services cover the development and GMP-compliant production of mammalian cell and microbial-derived biopharmaceuticals, including protein-based therapeutics and antibodies. The company is committed to technological innovation and adhering to international standards to address global health challenges.

Recent filings

Filing Released Lang Actions
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (Eubiologics) detailing a 'Change in Major Shareholder's Stock Collateral Agreement'. It provides specific details on collateralized shares, loan amounts, and creditor information. This type of disclosure regarding the pledging of shares by a major shareholder is a standard regulatory requirement in the Korean market (DART system) and falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which usually refers to personal trades) or 'Share Issue'.
2021-06-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory disclosure for insider trading or changes in share ownership by company executives. According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2021-06-03 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (Eubiologics) regarding a 'Correction Report' (정정신고) for a 'Stock Collateral Agreement' (주식 담보제공 계약). This type of filing, which details changes in collateral terms for shares held by a major shareholder, falls under the category of general regulatory announcements and disclosures that do not fit into specific financial reporting or corporate action categories like dividends or M&A. Therefore, it is classified as a Regulatory Filing (RNS).
2021-05-21 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'EuBiologics Co., Ltd.' covering the period from January 1, 2021, to March 31, 2021. It contains detailed financial statements, business descriptions, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This type of filing is a mandatory disclosure for company insiders (directors/executives) to report changes in their personal shareholdings, which corresponds to the 'Director's Dealing' category.
2021-04-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Park Jong Ho) of Eubiologics. This type of filing, which details personal share transactions (insider trading) by company directors or executives, is classified as 'Director's Dealing' (DIRS) in the provided schema.
2021-04-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.